Singulariti × Vanda Pharmaceuticals — Pharma Compliance Layer
Every ad, landing page, email, SMS, and TV script passes the compliance gate before it can ship. Claims must be cited to the bank. Fair balance is enforced. Platform rules are applied. The gate blocks; med-legal approves; the asset ships.
01 / The Gate
This is the live engine — the same one that runs in the CI pipeline on every asset. Pick the asset, paste the copy, watch it get judged in real time.
02 / The Generator
Give it the objective. It drafts the asset from the claims bank and the platform rules, runs its own draft through the gate, and rewrites on every BLOCK until it passes. Voice: it starts tone-blind — feed it the client's real copy and it writes more like them, with every sample.
03 / The Pipeline
The gate mirrors the tier model we run internally: reads are free, acting is earned. Nothing reaches a patient that the gate didn't clear and a human didn't approve.
Creative, landing, email, SMS, TV script — produced from the claims bank and platform rules, in the client's voice when the voice library has samples. This page is that step, live.
Automatic, in seconds. Claims checked against the bank, banned patterns, fair balance, disclaimers, platform rules. BLOCK fails the step. PASS files the proposal.
Tier-2 — human judgment. The proposal lands with the full gate report: every claim, its citation, every check and its result. One review, complete evidence.
Approved assets go live and stay watched: live-page render checks, ad-spend anomalies, and a regulatory watch that re-scans running creative when anything changes upstream.
04 / The Claims Bank
The claims bank is the single source of truth for what we may say, product by product. The gate detects a claim in copy and refuses to pass the asset unless that claim is cited. Citation IDs below are seeds — Vanda's med-legal confirms and locks them at onboarding.
05 / The Rules
Banned and strong-claim patterns (global), plus the rule set per platform. Each rule carries the reason — so a fix is a decision, not a guess.
| Pattern | Severity | Why |
|---|
Regulatory anchors: FDA 21 CFR 202 (labeling), 21 CFR 205 (consumer advertising), FTC 16 CFR 255 (prescription drug advertising), CAN-SPAM, TCPA. The gate encodes these as checks; the reasons on each rule cite which one.